Endo International Ordinary Shares reported $2.75B in Current Assets for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Adamas Pharmaceuticals ADMS:US 108M 7.65M
Aerie Pharmaceuticals AERI:US $ 275.95M 13.07M
Amarin AMRN:US $ 963.03M 32.95M
Ani Pharmaceuticals ANIP:US $ 191.38M 415K
Biodelivery Sciences International BDSI:US $ 188.26M 7.8M
Bristol Myers Squibb BMY:US $ 31443M 2282M
Coherus Biosciences CHRS:US $ 673.04M 13.03M
Eli Lilly And LLY:US $ 17808.3M 512.8M
Endo International Ordinary Shares ENDP:US $ 2748.95M 179.62M
Flexion Therapeutics FLXN:US $ 192.76M 8.64M
Heron Therapeutics HRTX:US $ 315.05M 51.77M
Hikma Pharmaceutical HIK:LN 1.96B 33M
Horizon Pharma HZNP:US $ 2413.92M 238.54M
JAZZ PHA JAZZ:US $ 2628.23M 325.74M
Lannett LCI:US $ 364.89M 11.33M
Ligand Pharmaceuticals LGND:US $ 432.08M 21.18M
Novartis NOVN:VX 26.25B 2.45B
Pacira Pharmaceuticals PCRX:US $ 822.35M 29.77M
Patterson Companies PDCO:US $ 1799.43M 187.95M
Perrigo Ordinary Shares PRGO:US $ 4225.9M 194.3M
Phibro Animal Health PAHC:US $ 498.63M 0.28M
Revance Therapeutics RVNC:US $ 293.88M 60.72M
Supernus Pharmaceuticals SUPN:US $ 668.38M 29.13M
Takeda 4502:JP Y 2456353M 20105M
Teva Pharmaceutical TEVA:IT 12.15B 668M
Xeris Pharmaceuticals Inc XERS:US $ 124.37M 20.22M
Zoetis ZTS:US $ 6682M 366M